Wang HB - Search Results

1

The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.

Zhang Y, Wang HB, Chi LJ, Wang WZ. Zhang Y, et al. Among authors: wang wz, wang hb. Immunol Lett. 2009 Jan 29;122(1):52-7. doi: 10.1016/j.imlet.2008.11.015. Epub 2008 Dec 25. Immunol Lett. 2009. PMID: 19111574

2

Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.

Chi LJ, Wang HB, Zhang Y, Wang WZ. Chi LJ, et al. Among authors: wang wz, wang hb. J Neuroimmunol. 2007 Dec;192(1-2):206-14. doi: 10.1016/j.jneuroim.2007.09.034. Epub 2007 Nov 13. J Neuroimmunol. 2007. PMID: 17997492

3

Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Chi LJ, Wang HB, Wang WZ. Chi LJ, et al. Among authors: wang wz, wang hb. J Peripher Nerv Syst. 2008 Mar;13(1):54-63. doi: 10.1111/j.1529-8027.2008.00158.x. J Peripher Nerv Syst. 2008. PMID: 18346231

4

[Mechanism of cellular immunity accommodation in prophylactic effects of nasal tolerance with dual analogue on experimental autoimmune myasthenia gravis in Lewis rats].

Wang LH, Wang HB, Tian QH, Fu YH, Wang WZ. Wang LH, et al. Among authors: wang wz, wang hb. Zhonghua Yu Fang Yi Xue Za Zhi. 2004 Jul;38(4):244-7. Zhonghua Yu Fang Yi Xue Za Zhi. 2004. PMID: 15312583 Chinese.

5

The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat.

Huang XN, Wang WZ, Fu J, Wang HB. Huang XN, et al. Among authors: wang wz, wang hb. Anat Rec (Hoboken). 2011 Jan;294(1):46-54. doi: 10.1002/ar.21286. Epub 2010 Nov 12. Anat Rec (Hoboken). 2011. PMID: 21157915 Free article.

6

Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk.

Jiao H, Wang W, Wang H, Wu Y, Wang L. Jiao H, et al. Mol Biol Rep. 2012 Feb;39(2):1537-40. doi: 10.1007/s11033-011-0892-1. Epub 2011 May 22. Mol Biol Rep. 2012. PMID: 21604171

7

Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis.

Wang HB, Li H, Shi FD, Chambers BJ, Link H, Ljunggren HG. Wang HB, et al. Int Immunol. 2000 Oct;12(10):1381-8. doi: 10.1093/intimm/12.10.1381. Int Immunol. 2000. PMID: 11007755

8

[Identification of correlations between numbers of CD4+ CD25+ Treg cells, levels of sera anti-AChR antibodies and transfer growth factor-beta in patients with myasthenia gravis].

Wang HB, Zhang JB, Chui LY. Wang HB, et al. Zhonghua Yi Xue Za Zhi. 2008 Apr 15;88(15):1036-40. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18754436 Chinese.

9

Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis.

Duan RS, Wang HB, Yang JS, Scallon B, Link H, Xiao BG. Duan RS, et al. Among authors: wang hb. J Autoimmun. 2002 Dec;19(4):169-74. doi: 10.1006/jaut.2002.0618. J Autoimmun. 2002. PMID: 12473237

10

Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.

Wang HB, Shi FD, Li H, Chambers BJ, Link H, Ljunggren HG. Wang HB, et al. J Immunol. 2001 May 15;166(10):6430-6. doi: 10.4049/jimmunol.166.10.6430. J Immunol. 2001. PMID: 11342669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,444 results

Search Page

Filters